These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23598723)

  • 21. Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.
    Billings CG; Hurdman JA; Condliffe R; Elliot CA; Smith IA; Austin M; Armstrong IJ; Hamilton N; Charalampopoulos A; Sabroe I; Swift AJ; Rothman AM; Wild JM; Lawrie A; Waterhouse JC; Kiely DG
    J Heart Lung Transplant; 2017 Aug; 36(8):871-879. PubMed ID: 28579006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
    Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
    JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension.
    Żyłkowska J; Kurzyna M; Florczyk M; Burakowska B; Grzegorczyk F; Burakowski J; Wieteska M; Oniszh K; Biederman A; Wawrzyńska L; Szturmowicz M; Fijałkowska A; Torbicki A
    Chest; 2012 Dec; 142(6):1406-1416. PubMed ID: 22797193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-risk echocardiographic features predict mortality in pulmonary arterial hypertension.
    Austin C; Burger C; Kane G; Safford R; Blackshear J; Ung R; Ray J; Alsaad A; Alassas K; Shapiro B
    Am Heart J; 2017 Jul; 189():167-176. PubMed ID: 28625373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival.
    Cogswell R; Kobashigawa E; McGlothlin D; Shaw R; De Marco T
    J Heart Lung Transplant; 2012 Nov; 31(11):1165-70. PubMed ID: 23062726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
    Frost AE; Badesch DB; Barst RJ; Benza RL; Elliott CG; Farber HW; Krichman A; Liou TG; Raskob GE; Wason P; Feldkircher K; Turner M; McGoon MD
    Chest; 2011 Jan; 139(1):128-37. PubMed ID: 20558556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension.
    Henkens IR; Van Wolferen SA; Gan CT; Boonstra A; Swenne CA; Twisk JW; Kamp O; van der Wall EE; Schalij MJ; Vonk-Noordegraaf A; Vliegen HW
    Am J Cardiol; 2009 May; 103(10):1451-6. PubMed ID: 19427445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.
    Benza RL; Gomberg-Maitland M; Miller DP; Frost A; Frantz RP; Foreman AJ; Badesch DB; McGoon MD
    Chest; 2012 Feb; 141(2):354-362. PubMed ID: 21680644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
    Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Traditional systolic blood pressure targets underestimate hypotension-induced secondary brain injury.
    Brenner M; Stein DM; Hu PF; Aarabi B; Sheth K; Scalea TM
    J Trauma Acute Care Surg; 2012 May; 72(5):1135-9. PubMed ID: 22673237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low systolic blood pressure and high resting heart rate as predictors of outcome in patients with peripartum cardiomyopathy.
    Libhaber E; Sliwa K; Bachelier K; Lamont K; Böhm M
    Int J Cardiol; 2015; 190():376-82. PubMed ID: 25966297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of systolic blood pressure combined with heart rate measured on admission to identify 1-year all-cause mortality risk in elderly patients firstly hospitalized due to acute heart failure.
    Moreno-González R; Formiga F; Mora Lujan JM; Chivite D; Ariza-Solé A; Corbella X
    Aging Clin Exp Res; 2020 Jan; 32(1):99-106. PubMed ID: 30790241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension.
    Kane GC; Maradit-Kremers H; Slusser JP; Scott CG; Frantz RP; McGoon MD
    Chest; 2011 Jun; 139(6):1285-1293. PubMed ID: 21071530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction.
    Schirmer SH; Sayed MM; Reil JC; Ukena C; Linz D; Kindermann M; Laufs U; Mahfoud F; Böhm M
    J Am Coll Cardiol; 2014 May; 63(18):1916-23. PubMed ID: 24315919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.
    Benza RL; Kanwar MK; Raina A; Scott JV; Zhao CL; Selej M; Elliott CG; Farber HW
    Chest; 2021 Jan; 159(1):337-346. PubMed ID: 32882243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world, long-term survival of incident patients with pulmonary arterial hypertension.
    Marques-Alves P; Baptista R; Marinho da Silva A; Pêgo M; Castro G
    Rev Port Pneumol (2006); 2017; 23(3):124-131. PubMed ID: 28283462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.
    Cracowski JL; Degano B; Chabot F; Labarère J; Schwedhelm E; Monneret D; Iuliano L; Schwebel C; Chaouat A; Reynaud-Gaubert M; Faure P; Maas R; Renversez JC; Cracowski C; Sitbon O; Yaïci A; Simonneau G; Humbert M
    Chest; 2012 Oct; 142(4):869-876. PubMed ID: 22406961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.